Gochi, A., Orita, K., Fuchimoto, S., Tanaka, N., & Ogawa, N. (2001). The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients. Nature Publishing Group.
Chicago-stil citatGochi, A., K. Orita, S. Fuchimoto, N. Tanaka, och N. Ogawa. The Prognostic Advantage of Preoperative Intratumoral Injection of OK-432 for Gastric Cancer Patients. Nature Publishing Group, 2001.
MLA-referensGochi, A., et al. The Prognostic Advantage of Preoperative Intratumoral Injection of OK-432 for Gastric Cancer Patients. Nature Publishing Group, 2001.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.